As per the World Health Organization (WHO), approximately 11% of the diseases globally are taking place owing to malnutrition and hence are posing a risk to the life of human beings. If this count increases in forthcoming years, then problems of food security and political unrest will emerge, providing impetus to the development of the global parenteral nutrition market.
The report covers a detailed understanding of the forces driving and restraining the development of the global parenteral nutrition market. Market attractiveness analysis also forms a key part of this report in addition to the employment of tools such as Porter’s five forces model in order to present the degree of competition prevalent in the market. Furthermore, market share analysis with respect to different regions also forms an integral part of this study.
The top segments and sub-segments present in the market and their expected state by the end of the forecast period have also been presented. The competitive landscape section of the study encapsulates the leading vendors in the market, their key weaknesses and strengths, and top product introductions.
This 101 page report gives readers a comprehensive overview of the Parenteral Nutrition Market. Unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/parenteral-nutrition-market.html
The global parenteral nutrition market is fuelled by the increasing occurrence of chronic diseases such as Crohn’s disease, diabetic complications, ischemic bowel disease, gastro-intestinal disorders, and cancer. In addition, the soaring count of malnourished children, particularly within emerging nations resulting in the increasing natality rate will positively impact the development of the global parenteral nutrition market. Furthermore, the increasing aging population suffering from deficiency of several essential nutrients will stimulate the growth of the market.
On the other hand, the market for parenteral nutrition is restrained due to the increasing health risks incurred owing to poor monitoring. In addition, muscle pain, allergic reactions, unexplained gaining of weight, and shortness of breath are also some of the other side effects related to parenteral nutrition. Furthermore, consistent utilization of parenteral nutrition therapy may result in liver diseases and metabolic complications, as per The American Society for Nutrition. These factors will further negatively impact the growth of the global parenteral nutrition market.
Get accurate market forecast and analysis on the Parenteral Nutrition Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611
Geographically, the report segments the global parenteral nutrition market into Latin America (LATAM), Asia Pacific, Europe, North America, and the Middle East and Africa (MEA). Of these, North America led the market for parenteral nutrition in 2014 and constituted an approximate share of 40.1%. This region is poised to maintain its superiority all through the forecast period. This is owing to the favorable insurance policies covering all the parenteral nutrition expenditures within this region. In addition, both in Canada and the U.S., the parenteral nutrition market will rise owing to increasing count of patients having cancer and diabetes. Furthermore, a number of companies have also put in efforts to increase their operations within Canada, thus boosting the growth of the North America parenteral nutrition market.
On the other hand, the Asia Pacific parenteral nutrition market is predicted to rise at the swiftest CAGR of 7.30% from 2015 to 2023. This is owing to the advancement of pharmaceutical markets in nations such as Thailand, Taiwan, Singapore, Indonesia, China, and India. In addition, the increasing preterm birth cases, resulting in malnutrition will further boost the growth of this market in Asia Pacific.
The leading players in the global parenteral nutrition market are Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius SE & Co. KGaA, Grifols S.A., Allergan plc (Actavis plc), Baxter International, Inc., and Pfizer, Inc. (Hospira, Inc.) amongst others.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453